Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Net Cash Flow (2023 - 2025)

Metagenomi (MGX) has disclosed Net Cash Flow for 3 consecutive years, with $8.9 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 291.98% to $8.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.3 million through Dec 2025, up 112.61% year-over-year, with the annual reading at $14.3 million for FY2025, 112.61% up from the prior year.
  • Net Cash Flow for Q4 2025 was $8.9 million at Metagenomi, up from $5.9 million in the prior quarter.
  • The five-year high for Net Cash Flow was $50.2 million in Q3 2023, with the low at -$88.8 million in Q1 2023.
  • Average Net Cash Flow over 3 years is -$12.0 million, with a median of -$268000.0 recorded in 2025.
  • The sharpest move saw Net Cash Flow tumbled 171.77% in 2024, then soared 291.98% in 2025.
  • Over 3 years, Net Cash Flow stood at $38.7 million in 2023, then crashed by 94.14% to $2.3 million in 2024, then skyrocketed by 291.98% to $8.9 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $8.9 million, $5.9 million, and -$2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.